Methelina en es it fr

Methelina Brand names, Methelina Analogs

Methelina Brand Names Mixture

  • No information avaliable

Methelina Chemical_Formula


Methelina RX_link

No information avaliable

Methelina fda sheet

Methelina msds (material safety sheet)

Methelina Synthesis Reference

No information avaliable

Methelina Molecular Weight

340.436 g/mol

Methelina Melting Point

No information avaliable

Methelina H2O Solubility

No information avaliable

Methelina State


Methelina LogP

No information avaliable

Methelina Dosage Forms

Tablet (50 mg)

Methelina Indication

For the treatment of peptic ulcer disease, irritable bowel syndrome, pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, and reflex neurogenic bladder in children.

Methelina Pharmacology

Methantheline is a synthetic quarternary ammonium antimuscarinic used to relieve cramps or spasms of the stomach, intestines, and bladder. It can be used together with antacids or other medicines, such as H2-receptor antagonists, in the treatment of peptic ulcer. Methantheline inhibits muscarinic actions at postganglionic parasympathetic neuroeffector sites.

Methelina Absorption

Rapidly absorbed.

Methelina side effects and Toxicity

Symptoms of overdose: blurred vision (continuing) or changes in near vision, clumsiness or unsteadiness, confusion, convulsions, difficulty in breathing, muscle weakness (severe), or tiredness (severe), dizziness, drowsiness (severe), dryness of mouth, nose, or throat (severe), fast heartbeat, fever, hallucinations, slurred speech, unusual excitement, nervousness, restlessness, or irritability, unusual warmth, dryness, and flushing of skin.

Methelina Patient Information

No information avaliable

Methelina Organisms Affected

Humans and other mammals